The term entourage effect originated in endocannabinoid research, where inactive lipid congeners enhanced the activity of a primary ligand within a mixture (Ben-Shabat et al., 1998). In cannabis science, the phrase has expanded to describe the idea that whole-plant preparations or multi-constituent extracts produce effects different from or greater than isolated cannabinoids through additive or synergistic interactions involving terpenes and other compounds (Russo, 2011). Reviews consistently note that this broader usage encompasses multiple mechanisms and remains incompletely defined (André et al., 2024; Anand et al., 2021).
Evidence consistent with terpene involvement
The most direct experimental support for terpene participation at cannabinoid receptors comes from in vitro work. Raz et al. (2023) reported that several terpenes produced weak partial CB1 activation and that certain terpene–THC combinations increased signaling beyond THC alone. The effect depended on concentration. These data demonstrate interaction in a controlled receptor system but do not establish clinical relevance.
Terpenes also possess activities at non-cannabinoid targets that could influence mixture outcomes. β-Caryophyllene is a CB2 agonist with a defined receptor mechanism that can contribute anti-inflammatory signaling independent of CB1 (Gertsch et al., 2008). Myrcene activates transient receptor potential cation channel subfamily V member 1 (TRPV1) in cell systems, providing a route by which sensory or nociceptive signaling might change in the presence of cannabinoids without CB1 modulation (Jansen et al., 2019). The TRPV1, also known as the capsaicin receptor and the vanilloid receptor 1. Its function is detection and regulation of body temperature. In addition, TRPV1 provides a sensation of scalding heat and pain (nociception).
These findings support additivity across parallel pathways rather than direct receptor synergy.
Real-world observational data show associations between terpene profiles and patient-reported effects. Vigil et al. (2023) found correlations between chemovar composition and symptom outcomes across consumer reports. Because dose, expectation, and cannabinoid content vary simultaneously, these results indicate covariance, not causation.
Clinical trials comparing botanical extracts with different cannabinoid compositions are sometimes interpreted as entourage compatible. For example, Johnson et al. (2010) observed differences between THC-dominant and THC:CBD preparations in cancer pain. Such results primarily demonstrate cannabinoid–cannabinoid interaction and do not isolate terpene mechanisms.
Evidence arguing against CB1/CB2 mediation by terpenes
Santiago et al. (2019) reported that common terpenoids neither activated CB1/CB2 nor altered Δ9-THC responses in their assay system. Finlay et al. (2020) similarly detected no meaningful modulation of receptor binding or function, aside from limited CB2 activity attributable to β-caryophyllene. These studies show that terpene effects are not robust across experimental platforms.
The entourage may occur via multiple pathways, including enhancement at CB1, contribution through CB2, modulation of TRP channels, and alteration of perception through olfactory or arousal pathways, all of which are different mechanisms (André et al., 2024; Ben-Shabat et al., 1998). A study designed to detect one will not necessarily detect another.
Assay architecture also matters. Santiago et al. (2019) and Raz et al. (2023) used different systems and endpoints. Divergent outcomes under such conditions are expected when effects are small or conditional.
Translation introduces additional constraints. Terpene volatility, metabolism, and distribution determine whether concentrations achieved in vivo can approach those used in vitro (André et al., 2024). Observational human data cannot disentangle these variables (Vigil et al., 2023).
Terpene stability during processing and storage
Volatility and chemical lability strongly influence whether terpenes remain available to exert any effect. Heating, grinding, and air exposure promote evaporative loss. Studies of decarboxylation workflows show that conventional approaches deplete monoterpenes unless vapor capture is engineered (Boffa et al., 2024). Direct comparisons between flower and derived extracts document large reductions in the most volatile fractions following routine processing (Raz et al., 2022).
Oxidative change continues during handling and decontamination. Hazekamp (2016) showed that terpene quantities can decline while oxidation products rise, altering composition even when the overall profile appears similar.
Storage conditions further determine persistence. Bueno et al. (2021) demonstrated measurable change over time, with outcomes governed by packaging and headspace control.
Chacon et al. (2024) showed that hydro distillation, supercritical CO₂, and ethanol extraction applied to identical material yield markedly different terpene abundances. Namdar et al. (2018) similarly demonstrated that measured composition reflects plant material plus method. The terpene signature of a retail extract is therefore a process outcome.
Because receptor modulation requires sufficient concentration at the site of action, depletion during manufacture and shelf life imposes a practical limit. Monoterpenes are therefore less likely than more stable sesquiterpenes such as β-caryophyllene to remain at meaningful levels in many finished products.
Ratio dependence in other sciences
Non-linear mixture behavior is routine in antimicrobial, sensory, and ecological research. Changing proportion can convert additivity to synergy or antagonism (Bassolé et al., 2011; Trombetta et al., 2009). Odor perception varies with relative abundance (Laing et al., 2001). Insects often respond only within narrow blend windows (Linn & Roelofs, 2002). These data confirm that ratio logic is biologically real. They do not demonstrate operation at cannabinoid receptors.
Several principles develop from these studies.
· Terpenes can interact.
· Their joint behavior can be non-linear so that emergent properties appear.
· Optimal effects may depend on ratio rather than mere presence.
However, translation requires matching context, and the contexts differ in fundamental ways.
Antimicrobial studies involve direct contact with microbial membranes at concentrations far higher than those typically measured systemically after human cannabis use. Olfactory and pheromonal systems involve receptor families and neural architectures specialized for volatile detection. Cannabinoid pharmacology, in contrast, usually interrogates G-protein coupled receptors such as CB1 and CB2, downstream intracellular signaling cascades, and central nervous system distribution following inhalation or ingestion. And the routes of administration can vary the pharmacokinetic distribution of ingested compounds.
For this reason, investigators frequently cite antimicrobial or sensory mixture studies to support plausibility arguments. They show that nature permits ratio logic. What they do not show is that any given terpene proportion will enhance THC or CBD efficacy, alter therapeutic index, or modify clinical outcomes.
References
1. André, R., Gomes, A. P., Pereira-Leite, C., Marques-da-Costa, A., Rodrigues, L. M., Sassano, M., Rijo, P., & Costa, M. C. (2024). The entourage effect in cannabis medicinal products: A comprehensive review. Pharmaceuticals, 17(11), 1543. https://doi.org/10.3390/ph17111543
2. Anand, U., Pacchetti, B., Anand, P., & Sodergren, M. H. (2021). Cannabis-based medicines and pain: A review of potential synergistic and entourage effects. Pain Management, 11(4), 395–403. https://doi.org/10.2217/pmt-2020-0110
3. Bassolé, I. H. N., Lamien-Meda, A., Bayala, B., Tirogo, S., Franz, C., Novak, J., Nebié, R. C., & Dicko, M. H. (2011). Antimicrobial activity of essential oil components and their potential synergy in combinations against pathogenic bacteria. Molecules, 16(1), 425–438. https://doi.org/10.3390/molecules16010425
4. Ben-Shabat, S., Fride, E., Sheskin, T., Tamiri, T., Rhee, M. H., Vogel, Z., Bisogno, T., De Petrocellis, L., Di Marzo, V., & Mechoulam, R. (1998). An entourage effect: Inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity. European Journal of Pharmacology, 353(1), 23–31. https://doi.org/10.1016/S0014-2999(98)00392-6
5. Boffa, L., Binello, A., & Cravotto, G. (2024). Efficient capture of cannabis terpenes in olive oil during microwave-assisted cannabinoid decarboxylation. Molecules, 29(4), 899. https://doi.org/10.3390/molecules29040899
6. Bueno, J., Greenbaum, E., et al. (2021). The preservation and augmentation of volatile terpenes in cannabis inflorescence. Journal of Cannabis Research, 3, Article 3. https://doi.org/10.1186/s42238-020-00035-z
7. Chacon, F. T., Raup-Konsavage, W. M., Vrana, K. E., & Kellogg, J. J. (2024). Effect of hemp extraction procedures on cannabinoid and terpenoid composition. Plants, 13(16), 2222. https://doi.org/10.3390/plants13162222
8. Finlay, D. B., Sircombe, K. J., Nimick, M., Jones, C., & Glass, M. (2020). Terpenoids from cannabis do not mediate an entourage effect by acting at cannabinoid receptors. Frontiers in Pharmacology, 11, 359. https://doi.org/10.3389/fphar.2020.00359
9. Gertsch, J., Leonti, M., Raduner, S., Racz, I., Chen, J. Z., Xie, X. Q., Altmann, K.-H., Karsak, M., & Zimmer, A. (2008). Beta-caryophyllene is a dietary cannabinoid. Proceedings of the National Academy of Sciences of the United States of America, 105(26), 9099–9104. https://doi.org/10.1073/pnas.0803601105
10. Hazekamp, A. (2016). Evaluating the effects of gamma-irradiation for decontamination of medicinal cannabis. Frontiers in Pharmacology, 7, 108. https://doi.org/10.3389/fphar.2016.00108
11. Jansen, C., Shimoda, L. M. N., Kawakami, J. K., Ang, L., Bacani, A. J., Baker, J. D., Badowski, C., Speck, M., Stokes, A. J., Small-Howard, A. L., & Turner, H. (2019). Myrcene and terpene regulation of TRPV1. Channels, 13(1), 344–366. https://doi.org/10.1080/19336950.2019.1654347
12. Johnson, J. R., Burnell-Nugent, M., Lossignol, D., Ganae-Motan, E. D., Potts, R., & Fallon, M. T. (2010). Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain. Journal of Pain and Symptom Management, 39(2), 167–179. https://doi.org/10.1016/j.jpainsymman.2009.06.008
13. Laing, D. G., Eddy, A., Francis, G. W., & Stephens, L. (2001). Odor interactions: Studies on binary mixtures of odorants. Physiology & Behavior, 72(1–2), 209–218. https://doi.org/10.1016/S0031-9384(00)00404-6
14. Namdar, D., Mazuz, M., Ion, A., & Koltai, H. (2018). Variation in the compositions of cannabinoid and terpenoids in Cannabis sativa derived from inflorescence position along the stem and extraction methods. Industrial Crops and Products, 113, 376–382. https://doi.org/10.1016/j.indcrop.2018.01.060
15. Raz, N., Eyal, A. M., Zeitouni, D. B., Hen-Shoval, D., Davidson, E. M., Danieli, A., Tauber, M., & Ben-Chaim, Y. (2023). Selected cannabis terpenes synergize with THC to produce increased CB1 receptor activation. Biochemical Pharmacology, 212, 115548. https://doi.org/10.1016/j.bcp.2023.115548
16. Raz, N., et al. (2022). Optimal treatment with cannabis extracts formulations is gained via knowledge of their terpene content and via enrichment with specifically selected monoterpenes and monoterpenoids. Molecules, 27(20), 6920. https://doi.org/10.3390/molecules27206920
17. Russo, E. B. (2011). Taming THC: Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology, 163(7), 1344–1364. https://doi.org/10.1111/j.1476-5381.2011.01238.x
18. Santiago, M., Sachdev, S., Arnold, J. C., McGregor, I. S., & Connor, M. (2019). Absence of entourage: Terpenoids commonly found in Cannabis sativa do not modulate the functional activity of Δ9-THC at human CB1 and CB2 receptors. Cannabis and Cannabinoid Research, 4(3), 165–176. https://doi.org/10.1089/can.2019.0016
19. Vigil, J. M., Stith, S. S., Brockelman, F., Keeling, K., & Hall, B. (2023). Systematic combinations of major cannabinoid and terpene contents in Cannabis flower and patient outcomes: A proof-of-concept assessment of the Vigil Index of Cannabis Chemovars. Journal of Cannabis Research, 5(1), 4. https://doi.org/10.1186/s42238-022-00170-9